TABLE 6

Clinical impact of variations in α2-adrenoceptors

Data are an overview of candidate gene studies investigating >100 individuals.

α2-Subtype, VariationNumber of SubjectsPopulation OriginVariation EffectReference
Risk of (early onset) hypertension, blood pressure
 ADRA2B, c.901_909del (p.Glu301_Glu303del)109Italianins = delIacoviello et al. (2006)
155 HT sibling pairs Americanins = delBaldwin et al. (1999)
173Americanins = delEtzel et al. (2005)
943 HT (817 controls)Swedishins < delVon Wowern et al. (2004)
912Finnishins = delSnapir et al. (2001)
 ADRA2C, c.964_975del (p.Glu322_Glu325del)224 healthy individualsAmericanins = delKurnik et al. (2007)
3398Americanins = delLi et al. (2006)
Risk of cardiovascular event (stroke, myocardial infarction, cardiac death) 
 ADRA2B, c.901_909del (p.Glu301_Glu303del)616 IS (512 controls)Koreanins < delOh et al. (2013)
683Finnishins < delSnapir et al. (2003b)
912Finnishins < delSnapir et al. (2001)
1606Finnishins < delLaukkanen et al. (2009)
 ADRA2C, c.964_975del (p.Glu322_Glu325del)345 with DCMGermanins > delRegitz-Zagrosek et al. (2006)
601 with ACSAfrican Americanins = delCresci et al. (2012)
616 IS (512 controls) Koreanins = delOh et al. (2013)
2072 with ACSCaucasianins > delCresci et al. (2012)
Risk/onset of diabetes
 ADRA2B, c.901_909del (p.Glu301_Glu303del)T2D, 130 with diabetic neuropathy (60 controls)Greekins < del (diabetic neuropathy)Papanas et al. (2007)
199 with T2D (204 controls)Greekins < del (onset)Papazoglou et al. (2006)
506 with T2DFinnishins < delSiitonen et al. (2004)
996 with T1DFinnishins < del (onset)Heinonen et al. (2005)
ins = del (progression)
Obesity
 ADRA2B, c.901_909del (p.Glu301_Glu303del)909Greekins = delDionne et al. (2001)
  • ACS, acute coronary syndrome; DCM, dilated cardiomyopathy; HT, hypertensive; ins, insertion (indicates the wild-type variant); IS, ischemic stroke; onset ins < del, onset earlier for deletion; T1D, type 1 diabetes; T2D, type 2 diabetes.